OPENDEL

What this means for you

Registered since 07 May 2024. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number

79374942

Registration number

7376720

Mark type

Word mark

Filed

19 Apr 2023

Published for opposition

20 Feb 2024

Registered

07 May 2024

Goods and services

• Class 001 — Chemicals: Chemical preparations for scientific purposes, other than for medical or veterinary use; chemical substances for analyses in laboratories, other than for medical or veterinary purposes; chemical reagents, other than for medical or veterinary purposes; biochemical preparations for scientific purposes; buffer solutions for use in analytical chemistry; biochemical catalysts
• Class 005 — Pharmaceuticals: Chemico-pharmaceutical preparations for the treatment of diseases caused by bacteria; drugs for medical purposes, namely, pharmaceutical preparations for treating neurological disease, muscular disease, ischemic disease, renal disease, cancer; biological preparations for medical purposes for the treatment of tumors, cancer, precancerous lesions, chronic infections, autoimmune diseases, fatty liver, inflammatory bowel disease, cervical neoplasia, viral infections, metabolic diseases, immunodeficiency, osteoarthritis, thyroid disease, glycometabolism disease, bone metabolic disease, gonad disease, kidney disease, cardiovascular disease, hepatic fibrosis, anemia, inflammation diseases, hepatitis disease, epstein-barr (eb) viruses, hormonal diseases, allergic, immune disorder, torch infections and immunoglobulin diseases; antibiotics; medicines for human purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; medicines made of chinese traditional medicinal herbs; biochemical drugs for the treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, inflammatory disorders, dermatological conditions, oncological diseases, blood diseases, connective tissue disorders, ophthalmic diseases, and gastroenterological disorders; lotions for pharmaceutical purposes being medicated lotions for treating dermatological conditions; chemical preparations for pharmaceutical purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; allergy tablets; antibiotic tablets; vitamin tablets; effervescent vitamin tablets
• Class 042 — Scientific and technological services: Technological research in the field of medical and healthcare; conducting technical project studies for determining the feasibility of new technologies; research and development of new products for others; scientific laboratory services; product quality evaluation; quality evaluation services for the medical and anesthesia industries; chemical research; chemistry consultation; chemical analysis; bacteriological research; biological research

Owner

• HitGen Inc., CN
• HitGen Inc., CN
• HitGen Inc., CN

Prosecution history

• 10 Jan 2025 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
• 22 Dec 2024 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
• 19 Dec 2024 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
• 19 Dec 2024 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
• 06 Jun 2024 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
• 06 Jun 2024 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
• 06 Jun 2024 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
• 07 May 2024 — REGISTERED-PRINCIPAL REGISTER
• 04 Mar 2024 — NOTIFICATION PROCESSED BY IB
• 20 Feb 2024 — PUBLISHED FOR OPPOSITION
• 14 Feb 2024 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
• 14 Feb 2024 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
• 31 Jan 2024 — NOTICE OF PUBLICATION
• 17 Jan 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
• 17 Jan 2024 — ASSIGNED TO EXAMINER